Life Science Investing Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
Life Science Investing Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
Life Science Investing Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
Life Science Investing Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
Life Science Investing Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
RZOLV Technologies Announces Independent SGS Lab-Scale Test Results on Gravity Concentrates - 98.7% Gold Recoveries
RZOLV Technologies Announces Independent SGS Lab-Scale Test Results on Gravity Concentrates - 98.7% Gold Recoveries
NextSource Materials Executes Term Sheets with Strategic Investors and Local Capital Partners to Advance Towards Final Investment Decision for its Proposed UAE Battery Anode Facility
